nodes	percent_of_prediction	percent_of_DWPC	metapath
Canagliflozin—ABCC2—primary biliary cirrhosis	0.356	0.722	CbGaD
Canagliflozin—ABCC2—Ursodeoxycholic acid—primary biliary cirrhosis	0.178	0.612	CbGbCtD
Canagliflozin—ALB—primary biliary cirrhosis	0.137	0.278	CbGaD
Canagliflozin—CYP3A4—Chenodeoxycholic acid—primary biliary cirrhosis	0.0482	0.165	CbGbCtD
Canagliflozin—ABCB1—Colchicine—primary biliary cirrhosis	0.0407	0.139	CbGbCtD
Canagliflozin—ABCC2—bile canaliculus—primary biliary cirrhosis	0.0305	0.429	CbGeAlD
Canagliflozin—CYP3A4—Colchicine—primary biliary cirrhosis	0.0244	0.0836	CbGbCtD
Canagliflozin—ABCC2—bile duct—primary biliary cirrhosis	0.00952	0.134	CbGeAlD
Canagliflozin—ORM1—bile—primary biliary cirrhosis	0.00891	0.125	CbGeAlD
Canagliflozin—ABCC2—bile—primary biliary cirrhosis	0.00732	0.103	CbGeAlD
Canagliflozin—SLC5A1—epithelium—primary biliary cirrhosis	0.00386	0.0544	CbGeAlD
Canagliflozin—ORM1—gall bladder—primary biliary cirrhosis	0.00247	0.0348	CbGeAlD
Canagliflozin—ALB—gall bladder—primary biliary cirrhosis	0.00217	0.0305	CbGeAlD
Canagliflozin—UGT2B4—liver—primary biliary cirrhosis	0.00202	0.0284	CbGeAlD
Canagliflozin—Nocturia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00168	0.022	CcSEcCtD
Canagliflozin—Nocturia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00168	0.022	CcSEcCtD
Canagliflozin—Rash maculo-papular—Colchicine—primary biliary cirrhosis	0.00158	0.0206	CcSEcCtD
Canagliflozin—Bladder pain—Colchicine—primary biliary cirrhosis	0.00157	0.0205	CcSEcCtD
Canagliflozin—Cystitis noninfective—Ursodeoxycholic acid—primary biliary cirrhosis	0.00152	0.0199	CcSEcCtD
Canagliflozin—Cystitis noninfective—Chenodeoxycholic acid—primary biliary cirrhosis	0.00152	0.0199	CcSEcCtD
Canagliflozin—Cystitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00151	0.0197	CcSEcCtD
Canagliflozin—Cystitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00151	0.0197	CcSEcCtD
Canagliflozin—Vaginal infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00147	0.0193	CcSEcCtD
Canagliflozin—Vaginal infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00147	0.0193	CcSEcCtD
Canagliflozin—Bladder pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00141	0.0185	CcSEcCtD
Canagliflozin—Bladder pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00141	0.0185	CcSEcCtD
Canagliflozin—UGT1A9—liver—primary biliary cirrhosis	0.00138	0.0194	CbGeAlD
Canagliflozin—Photosensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.00129	0.0169	CcSEcCtD
Canagliflozin—Photosensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.00129	0.0169	CcSEcCtD
Canagliflozin—ABCB1—Abacavir transmembrane transport—ABCG2—primary biliary cirrhosis	0.00122	0.018	CbGpPWpGaD
Canagliflozin—Blood creatinine increased—Colchicine—primary biliary cirrhosis	0.00118	0.0154	CcSEcCtD
Canagliflozin—Dehydration—Colchicine—primary biliary cirrhosis	0.00117	0.0153	CcSEcCtD
Canagliflozin—UGT1A9—Irinotecan Pathway—ABCG2—primary biliary cirrhosis	0.00117	0.0172	CbGpPWpGaD
Canagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC4A2—primary biliary cirrhosis	0.00116	0.0172	CbGpPWpGaD
Canagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC4A2—primary biliary cirrhosis	0.00116	0.0172	CbGpPWpGaD
Canagliflozin—ABCC2—Irinotecan Pathway—ABCG2—primary biliary cirrhosis	0.00114	0.0168	CbGpPWpGaD
Canagliflozin—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—primary biliary cirrhosis	0.0011	0.0162	CbGpPWpGaD
Canagliflozin—Blood creatinine increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00106	0.0139	CcSEcCtD
Canagliflozin—Blood creatinine increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00106	0.0139	CcSEcCtD
Canagliflozin—Dehydration—Chenodeoxycholic acid—primary biliary cirrhosis	0.00105	0.0138	CcSEcCtD
Canagliflozin—Dehydration—Ursodeoxycholic acid—primary biliary cirrhosis	0.00105	0.0138	CcSEcCtD
Canagliflozin—Orthostatic hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00103	0.0135	CcSEcCtD
Canagliflozin—Orthostatic hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00103	0.0135	CcSEcCtD
Canagliflozin—Breast disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00102	0.0134	CcSEcCtD
Canagliflozin—Breast disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00102	0.0134	CcSEcCtD
Canagliflozin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.001	0.0148	CbGpPWpGaD
Canagliflozin—ABCB1—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.000984	0.0145	CbGpPWpGaD
Canagliflozin—Pancreatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000959	0.0126	CcSEcCtD
Canagliflozin—Pancreatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000959	0.0126	CcSEcCtD
Canagliflozin—Pollakiuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000903	0.0118	CcSEcCtD
Canagliflozin—Pollakiuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000903	0.0118	CcSEcCtD
Canagliflozin—Photosensitivity reaction—Ursodeoxycholic acid—primary biliary cirrhosis	0.000893	0.0117	CcSEcCtD
Canagliflozin—Photosensitivity reaction—Chenodeoxycholic acid—primary biliary cirrhosis	0.000893	0.0117	CcSEcCtD
Canagliflozin—Urinary tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000848	0.0111	CcSEcCtD
Canagliflozin—Urinary tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000848	0.0111	CcSEcCtD
Canagliflozin—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000773	0.0101	CcSEcCtD
Canagliflozin—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000773	0.0101	CcSEcCtD
Canagliflozin—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000767	0.01	CcSEcCtD
Canagliflozin—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000767	0.01	CcSEcCtD
Canagliflozin—Malnutrition—Colchicine—primary biliary cirrhosis	0.000758	0.00993	CcSEcCtD
Canagliflozin—SLC5A1—NRF2 pathway—ABCC2—primary biliary cirrhosis	0.000735	0.0109	CbGpPWpGaD
Canagliflozin—SLC5A2—NRF2 pathway—ABCC2—primary biliary cirrhosis	0.000735	0.0109	CbGpPWpGaD
Canagliflozin—ORM1—liver—primary biliary cirrhosis	0.000725	0.0102	CbGeAlD
Canagliflozin—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.00071	0.0093	CcSEcCtD
Canagliflozin—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.00071	0.0093	CcSEcCtD
Canagliflozin—UGT1A9—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000708	0.0104	CbGpPWpGaD
Canagliflozin—ABCB1—Abacavir transport and metabolism—ABCG2—primary biliary cirrhosis	0.0007	0.0103	CbGpPWpGaD
Canagliflozin—Angioedema—Colchicine—primary biliary cirrhosis	0.000693	0.00907	CcSEcCtD
Canagliflozin—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.000681	0.00892	CcSEcCtD
Canagliflozin—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.000681	0.00892	CcSEcCtD
Canagliflozin—ALB—liver—primary biliary cirrhosis	0.000636	0.00896	CbGeAlD
Canagliflozin—Angioedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000623	0.00815	CcSEcCtD
Canagliflozin—Angioedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000623	0.00815	CcSEcCtD
Canagliflozin—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.000611	0.008	CcSEcCtD
Canagliflozin—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.000611	0.008	CcSEcCtD
Canagliflozin—Shock—Colchicine—primary biliary cirrhosis	0.000609	0.00797	CcSEcCtD
Canagliflozin—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.000607	0.00795	CcSEcCtD
Canagliflozin—CYP3A4—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.000606	0.00895	CbGpPWpGaD
Canagliflozin—Skin disorder—Colchicine—primary biliary cirrhosis	0.000601	0.00787	CcSEcCtD
Canagliflozin—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000599	0.00784	CcSEcCtD
Canagliflozin—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000599	0.00784	CcSEcCtD
Canagliflozin—ABCC2—liver—primary biliary cirrhosis	0.000596	0.00839	CbGeAlD
Canagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL12A—primary biliary cirrhosis	0.000594	0.00877	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	0.000592	0.00873	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	0.000592	0.00873	CbGpPWpGaD
Canagliflozin—Convulsion—Chenodeoxycholic acid—primary biliary cirrhosis	0.00059	0.00773	CcSEcCtD
Canagliflozin—Convulsion—Ursodeoxycholic acid—primary biliary cirrhosis	0.00059	0.00773	CcSEcCtD
Canagliflozin—Hypotension—Colchicine—primary biliary cirrhosis	0.000578	0.00757	CcSEcCtD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000576	0.00754	CcSEcCtD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000576	0.00754	CcSEcCtD
Canagliflozin—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.000567	0.00743	CcSEcCtD
Canagliflozin—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.000567	0.00743	CcSEcCtD
Canagliflozin—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000553	0.00723	CcSEcCtD
Canagliflozin—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000553	0.00723	CcSEcCtD
Canagliflozin—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.000547	0.00716	CcSEcCtD
Canagliflozin—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.000547	0.00716	CcSEcCtD
Canagliflozin—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000545	0.00714	CcSEcCtD
Canagliflozin—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000545	0.00714	CcSEcCtD
Canagliflozin—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00054	0.00707	CcSEcCtD
Canagliflozin—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00054	0.00707	CcSEcCtD
Canagliflozin—ABCB1—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.000539	0.00795	CbGpPWpGaD
Canagliflozin—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.000534	0.007	CcSEcCtD
Canagliflozin—Fatigue—Colchicine—primary biliary cirrhosis	0.000534	0.00699	CcSEcCtD
Canagliflozin—UGT2B4—Phase II conjugation—GGT1—primary biliary cirrhosis	0.000531	0.00784	CbGpPWpGaD
Canagliflozin—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00052	0.0068	CcSEcCtD
Canagliflozin—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00052	0.0068	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.000506	0.00663	CcSEcCtD
Canagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IGFBP1—primary biliary cirrhosis	0.000505	0.00746	CbGpPWpGaD
Canagliflozin—Urticaria—Colchicine—primary biliary cirrhosis	0.000492	0.00644	CcSEcCtD
Canagliflozin—Abdominal pain—Colchicine—primary biliary cirrhosis	0.000489	0.00641	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00048	0.00629	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00048	0.00629	CcSEcCtD
Canagliflozin—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000479	0.00628	CcSEcCtD
Canagliflozin—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000479	0.00628	CcSEcCtD
Canagliflozin—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000476	0.00623	CcSEcCtD
Canagliflozin—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000476	0.00623	CcSEcCtD
Canagliflozin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.000471	0.00695	CbGpPWpGaD
Canagliflozin—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—primary biliary cirrhosis	0.000462	0.00682	CbGpPWpGaD
Canagliflozin—SLC5A1—NRF2 pathway—GGT1—primary biliary cirrhosis	0.000459	0.00678	CbGpPWpGaD
Canagliflozin—SLC5A2—NRF2 pathway—GGT1—primary biliary cirrhosis	0.000459	0.00678	CbGpPWpGaD
Canagliflozin—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.000456	0.00597	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000455	0.00595	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000455	0.00595	CcSEcCtD
Canagliflozin—Asthenia—Colchicine—primary biliary cirrhosis	0.000444	0.00581	CcSEcCtD
Canagliflozin—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000442	0.00578	CcSEcCtD
Canagliflozin—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000442	0.00578	CcSEcCtD
Canagliflozin—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00044	0.00576	CcSEcCtD
Canagliflozin—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00044	0.00576	CcSEcCtD
Canagliflozin—SLC5A2—Carbohydrate metabolism—NUP210—primary biliary cirrhosis	0.000425	0.00628	CbGpPWpGaD
Canagliflozin—SLC5A1—Carbohydrate metabolism—NUP210—primary biliary cirrhosis	0.000425	0.00628	CbGpPWpGaD
Canagliflozin—SLC5A2—SLC-mediated transmembrane transport—NUP210—primary biliary cirrhosis	0.000424	0.00626	CbGpPWpGaD
Canagliflozin—SLC5A1—SLC-mediated transmembrane transport—NUP210—primary biliary cirrhosis	0.000424	0.00626	CbGpPWpGaD
Canagliflozin—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.00041	0.00536	CcSEcCtD
Canagliflozin—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.00041	0.00536	CcSEcCtD
Canagliflozin—UGT1A9—PPARA activates gene expression—ABCB4—primary biliary cirrhosis	0.000401	0.00592	CbGpPWpGaD
Canagliflozin—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000399	0.00522	CcSEcCtD
Canagliflozin—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000399	0.00522	CcSEcCtD
Canagliflozin—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000393	0.00515	CcSEcCtD
Canagliflozin—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000393	0.00515	CcSEcCtD
Canagliflozin—UGT1A9—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000393	0.0058	CbGpPWpGaD
Canagliflozin—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCB4—primary biliary cirrhosis	0.000393	0.0058	CbGpPWpGaD
Canagliflozin—Rash—Colchicine—primary biliary cirrhosis	0.00039	0.00511	CcSEcCtD
Canagliflozin—Dermatitis—Colchicine—primary biliary cirrhosis	0.00039	0.0051	CcSEcCtD
Canagliflozin—CYP3A4—Irinotecan Pathway—ABCC2—primary biliary cirrhosis	0.000388	0.00572	CbGpPWpGaD
Canagliflozin—ABCC2—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000384	0.00566	CbGpPWpGaD
Canagliflozin—ABCB1—epithelium—primary biliary cirrhosis	0.000378	0.00532	CbGeAlD
Canagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL12B—primary biliary cirrhosis	0.000373	0.00551	CbGpPWpGaD
Canagliflozin—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000368	0.00481	CcSEcCtD
Canagliflozin—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000368	0.00481	CcSEcCtD
Canagliflozin—Nausea—Colchicine—primary biliary cirrhosis	0.000368	0.00481	CcSEcCtD
Canagliflozin—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.000351	0.00459	CcSEcCtD
Canagliflozin—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.000351	0.00459	CcSEcCtD
Canagliflozin—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00035	0.00459	CcSEcCtD
Canagliflozin—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00035	0.00459	CcSEcCtD
Canagliflozin—SLC5A2—Carbohydrate metabolism—GOT2—primary biliary cirrhosis	0.000336	0.00496	CbGpPWpGaD
Canagliflozin—SLC5A1—Carbohydrate metabolism—GOT2—primary biliary cirrhosis	0.000336	0.00496	CbGpPWpGaD
Canagliflozin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.000332	0.0049	CbGpPWpGaD
Canagliflozin—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00033	0.00432	CcSEcCtD
Canagliflozin—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00033	0.00432	CcSEcCtD
Canagliflozin—CYP3A4—Irinotecan Pathway—ABCG2—primary biliary cirrhosis	0.00033	0.00486	CbGpPWpGaD
Canagliflozin—ABCB1—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000325	0.00479	CbGpPWpGaD
Canagliflozin—UGT2B4—Biological oxidations—GGT1—primary biliary cirrhosis	0.000311	0.00459	CbGpPWpGaD
Canagliflozin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000309	0.00457	CbGpPWpGaD
Canagliflozin—CYP3A4—liver—primary biliary cirrhosis	0.000303	0.00426	CbGeAlD
Canagliflozin—ABCB1—ABC-family proteins mediated transport—ABCC2—primary biliary cirrhosis	0.000295	0.00436	CbGpPWpGaD
Canagliflozin—SLC5A1—Carbohydrate metabolism—GOT1—primary biliary cirrhosis	0.00029	0.00428	CbGpPWpGaD
Canagliflozin—SLC5A2—Carbohydrate metabolism—GOT1—primary biliary cirrhosis	0.00029	0.00428	CbGpPWpGaD
Canagliflozin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.00029	0.00428	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—LBR—primary biliary cirrhosis	0.000277	0.00409	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—LBR—primary biliary cirrhosis	0.000277	0.00409	CbGpPWpGaD
Canagliflozin—ALB—FOXA2 and FOXA3 transcription factor networks—IGFBP1—primary biliary cirrhosis	0.000274	0.00404	CbGpPWpGaD
Canagliflozin—CYP3A4—Tryptophan metabolism—OGDH—primary biliary cirrhosis	0.000272	0.00401	CbGpPWpGaD
Canagliflozin—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—ABCB4—primary biliary cirrhosis	0.000271	0.00399	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	0.000246	0.00363	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	0.000246	0.00363	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	0.000236	0.00348	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	0.000236	0.00348	CbGpPWpGaD
Canagliflozin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A1—primary biliary cirrhosis	0.000225	0.00332	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	0.000215	0.00318	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	0.000215	0.00318	CbGpPWpGaD
Canagliflozin—ABCB1—liver—primary biliary cirrhosis	0.000214	0.00302	CbGeAlD
Canagliflozin—UGT2B4—Metabolism—LBR—primary biliary cirrhosis	0.000214	0.00316	CbGpPWpGaD
Canagliflozin—UGT1A9—NRF2 pathway—ABCC2—primary biliary cirrhosis	0.00021	0.0031	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—OGDH—primary biliary cirrhosis	0.0002	0.00296	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—OGDH—primary biliary cirrhosis	0.0002	0.00296	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	0.0002	0.00296	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	0.0002	0.00296	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—CXCR5—primary biliary cirrhosis	0.0002	0.00295	CbGpPWpGaD
Canagliflozin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.0002	0.00295	CbGpPWpGaD
Canagliflozin—UGT1A9—Phase II conjugation—GGT1—primary biliary cirrhosis	0.000197	0.0029	CbGpPWpGaD
Canagliflozin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—primary biliary cirrhosis	0.000196	0.0029	CbGpPWpGaD
Canagliflozin—UGT1A9—PPARA activates gene expression—CTGF—primary biliary cirrhosis	0.000192	0.00284	CbGpPWpGaD
Canagliflozin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000191	0.00281	CbGpPWpGaD
Canagliflozin—CYP3A4—Aflatoxin activation and detoxification—GGT1—primary biliary cirrhosis	0.000189	0.0028	CbGpPWpGaD
Canagliflozin—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—primary biliary cirrhosis	0.000188	0.00278	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—CXCL9—primary biliary cirrhosis	0.000182	0.00268	CbGpPWpGaD
Canagliflozin—ABCB1—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.00018	0.00266	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—PDHX—primary biliary cirrhosis	0.000179	0.00264	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—PDHX—primary biliary cirrhosis	0.000179	0.00264	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.000178	0.00262	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—IL12A—primary biliary cirrhosis	0.000177	0.00261	CbGpPWpGaD
Canagliflozin—ALB—SLC-mediated transmembrane transport—SLC4A2—primary biliary cirrhosis	0.000174	0.00257	CbGpPWpGaD
Canagliflozin—ABCB1—HIF-1-alpha transcription factor network—IGFBP1—primary biliary cirrhosis	0.000174	0.00256	CbGpPWpGaD
Canagliflozin—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—primary biliary cirrhosis	0.000169	0.00249	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—DLAT—primary biliary cirrhosis	0.000168	0.00248	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—ABCB4—primary biliary cirrhosis	0.000168	0.00248	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—ABCB4—primary biliary cirrhosis	0.000168	0.00248	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—DLAT—primary biliary cirrhosis	0.000168	0.00248	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	0.000165	0.00243	CbGpPWpGaD
Canagliflozin—ABCB1—HIF-1-alpha transcription factor network—ABCG2—primary biliary cirrhosis	0.000155	0.00228	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—OGDH—primary biliary cirrhosis	0.000155	0.00228	CbGpPWpGaD
Canagliflozin—SLC5A1—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	0.000154	0.00227	CbGpPWpGaD
Canagliflozin—SLC5A2—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	0.000154	0.00227	CbGpPWpGaD
Canagliflozin—UGT1A9—PPARA activates gene expression—PPARGC1A—primary biliary cirrhosis	0.000146	0.00216	CbGpPWpGaD
Canagliflozin—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARGC1A—primary biliary cirrhosis	0.000143	0.00211	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—ELMO1—primary biliary cirrhosis	0.000141	0.00208	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—ELMO1—primary biliary cirrhosis	0.000141	0.00208	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PDHX—primary biliary cirrhosis	0.000138	0.00204	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—CCL5—primary biliary cirrhosis	0.000132	0.00195	CbGpPWpGaD
Canagliflozin—UGT1A9—NRF2 pathway—GGT1—primary biliary cirrhosis	0.000131	0.00194	CbGpPWpGaD
Canagliflozin—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—primary biliary cirrhosis	0.00013	0.00191	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—ABCB4—primary biliary cirrhosis	0.00013	0.00191	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—DLAT—primary biliary cirrhosis	0.00013	0.00191	CbGpPWpGaD
Canagliflozin—ABCC2—NRF2 pathway—GGT1—primary biliary cirrhosis	0.000128	0.00189	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—NUP210—primary biliary cirrhosis	0.00012	0.00178	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—NUP210—primary biliary cirrhosis	0.00012	0.00178	CbGpPWpGaD
Canagliflozin—UGT1A9—Biological oxidations—GGT1—primary biliary cirrhosis	0.000115	0.0017	CbGpPWpGaD
Canagliflozin—UGT1A9—PPARA activates gene expression—AGT—primary biliary cirrhosis	0.000114	0.00168	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—DAG1—primary biliary cirrhosis	0.000112	0.00166	CbGpPWpGaD
Canagliflozin—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—primary biliary cirrhosis	0.000112	0.00165	CbGpPWpGaD
Canagliflozin—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000111	0.00164	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—IL12B—primary biliary cirrhosis	0.000111	0.00164	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	0.000108	0.00159	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—CTLA4—primary biliary cirrhosis	0.000104	0.00154	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—IL4—primary biliary cirrhosis	0.000104	0.00154	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—GGT1—primary biliary cirrhosis	0.000103	0.00152	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—NUP210—primary biliary cirrhosis	0.000101	0.00149	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—NUP210—primary biliary cirrhosis	0.000101	0.00149	CbGpPWpGaD
Canagliflozin—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARGC1A—primary biliary cirrhosis	9.87e-05	0.00146	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—GOT2—primary biliary cirrhosis	9.52e-05	0.00141	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—GOT2—primary biliary cirrhosis	9.52e-05	0.00141	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—ABCG2—primary biliary cirrhosis	9.38e-05	0.00138	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—ABCG2—primary biliary cirrhosis	9.38e-05	0.00138	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	9.31e-05	0.00137	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	8.85e-05	0.00131	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—GOT1—primary biliary cirrhosis	8.22e-05	0.00121	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—GOT1—primary biliary cirrhosis	8.22e-05	0.00121	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—CD40LG—primary biliary cirrhosis	8.12e-05	0.0012	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—CTGF—primary biliary cirrhosis	8.05e-05	0.00119	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—CTGF—primary biliary cirrhosis	8.05e-05	0.00119	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—GOT2—primary biliary cirrhosis	7.98e-05	0.00118	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—GOT2—primary biliary cirrhosis	7.98e-05	0.00118	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—LBR—primary biliary cirrhosis	7.92e-05	0.00117	CbGpPWpGaD
Canagliflozin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—primary biliary cirrhosis	7.9e-05	0.00117	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—IL4—primary biliary cirrhosis	7.9e-05	0.00117	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	7.82e-05	0.00115	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	7.82e-05	0.00115	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—NUP210—primary biliary cirrhosis	7.79e-05	0.00115	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	7.76e-05	0.00114	CbGpPWpGaD
Canagliflozin—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—primary biliary cirrhosis	7.69e-05	0.00114	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—ABCG2—primary biliary cirrhosis	7.24e-05	0.00107	CbGpPWpGaD
Canagliflozin—ABCB1—HIF-1-alpha transcription factor network—NOS2—primary biliary cirrhosis	7.19e-05	0.00106	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—RAD51B—primary biliary cirrhosis	7.09e-05	0.00105	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—GGT1—primary biliary cirrhosis	6.88e-05	0.00102	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—GOT1—primary biliary cirrhosis	6.88e-05	0.00102	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—GOT1—primary biliary cirrhosis	6.88e-05	0.00102	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—GGT1—primary biliary cirrhosis	6.88e-05	0.00102	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	6.85e-05	0.00101	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—PDE5A—primary biliary cirrhosis	6.59e-05	0.000973	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—NFKB1—primary biliary cirrhosis	6.43e-05	0.00095	CbGpPWpGaD
Canagliflozin—ALB—SLC-mediated transmembrane transport—NUP210—primary biliary cirrhosis	6.34e-05	0.000936	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—CTGF—primary biliary cirrhosis	6.21e-05	0.000917	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—GOT2—primary biliary cirrhosis	6.16e-05	0.000909	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—PPARGC1A—primary biliary cirrhosis	6.13e-05	0.000904	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—PPARGC1A—primary biliary cirrhosis	6.13e-05	0.000904	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—CD80—primary biliary cirrhosis	6.04e-05	0.000891	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	6.01e-05	0.000887	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—OGDH—primary biliary cirrhosis	5.72e-05	0.000845	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—HIF1A—primary biliary cirrhosis	5.72e-05	0.000844	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—HIF1A—primary biliary cirrhosis	5.72e-05	0.000844	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	5.64e-05	0.000833	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	5.58e-05	0.000824	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—GGT1—primary biliary cirrhosis	5.32e-05	0.000785	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—GOT1—primary biliary cirrhosis	5.32e-05	0.000785	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—NFKB1—primary biliary cirrhosis	5.23e-05	0.000773	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—primary biliary cirrhosis	5.23e-05	0.000772	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—NOS2—primary biliary cirrhosis	5.2e-05	0.000768	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—NOS2—primary biliary cirrhosis	5.2e-05	0.000768	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	5.16e-05	0.000762	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PDHX—primary biliary cirrhosis	5.1e-05	0.000753	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—CD80—primary biliary cirrhosis	5.05e-05	0.000745	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—CD80—primary biliary cirrhosis	5.05e-05	0.000745	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ABCB4—primary biliary cirrhosis	4.8e-05	0.000708	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—DLAT—primary biliary cirrhosis	4.8e-05	0.000708	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—AGT—primary biliary cirrhosis	4.77e-05	0.000704	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—AGT—primary biliary cirrhosis	4.77e-05	0.000704	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PPARGC1A—primary biliary cirrhosis	4.73e-05	0.000698	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	4.42e-05	0.000652	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—TYK2—primary biliary cirrhosis	4.26e-05	0.000629	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—TYK2—primary biliary cirrhosis	4.26e-05	0.000629	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—NFKB1—primary biliary cirrhosis	4.16e-05	0.000614	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—LBR—primary biliary cirrhosis	4.15e-05	0.000612	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	3.93e-05	0.00058	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—AGT—primary biliary cirrhosis	3.68e-05	0.000544	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	3.68e-05	0.000543	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—ALB—primary biliary cirrhosis	3.66e-05	0.000541	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—ALB—primary biliary cirrhosis	3.66e-05	0.000541	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—LBR—primary biliary cirrhosis	3.63e-05	0.000536	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	3.52e-05	0.00052	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—GGT1—primary biliary cirrhosis	3.25e-05	0.00048	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	3.22e-05	0.000476	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	3.22e-05	0.000475	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	3.09e-05	0.000456	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	3.06e-05	0.000452	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—OGDH—primary biliary cirrhosis	3e-05	0.000442	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	3e-05	0.000442	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—NUP210—primary biliary cirrhosis	2.88e-05	0.000426	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—ALB—primary biliary cirrhosis	2.83e-05	0.000417	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	2.82e-05	0.000417	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	2.7e-05	0.000399	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ABCG2—primary biliary cirrhosis	2.68e-05	0.000396	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PDHX—primary biliary cirrhosis	2.67e-05	0.000394	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—OGDH—primary biliary cirrhosis	2.63e-05	0.000388	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	2.63e-05	0.000388	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ABCB4—primary biliary cirrhosis	2.51e-05	0.000371	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—DLAT—primary biliary cirrhosis	2.51e-05	0.000371	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	2.35e-05	0.000347	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PDHX—primary biliary cirrhosis	2.34e-05	0.000346	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	2.31e-05	0.000341	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CTGF—primary biliary cirrhosis	2.3e-05	0.000339	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—GOT2—primary biliary cirrhosis	2.28e-05	0.000336	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—LBR—primary biliary cirrhosis	2.24e-05	0.00033	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ABCB4—primary biliary cirrhosis	2.2e-05	0.000325	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—DLAT—primary biliary cirrhosis	2.2e-05	0.000325	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	2.18e-05	0.000322	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	2.06e-05	0.000304	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—GOT1—primary biliary cirrhosis	1.97e-05	0.00029	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—GGT1—primary biliary cirrhosis	1.97e-05	0.00029	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	1.96e-05	0.000289	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PPARGC1A—primary biliary cirrhosis	1.75e-05	0.000258	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	1.62e-05	0.000239	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—NOS2—primary biliary cirrhosis	1.61e-05	0.000237	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.6e-05	0.000237	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—NUP210—primary biliary cirrhosis	1.51e-05	0.000223	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	1.44e-05	0.000213	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ABCG2—primary biliary cirrhosis	1.4e-05	0.000207	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—AGT—primary biliary cirrhosis	1.36e-05	0.000201	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	1.36e-05	0.0002	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	1.36e-05	0.0002	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—NUP210—primary biliary cirrhosis	1.32e-05	0.000195	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ABCG2—primary biliary cirrhosis	1.23e-05	0.000182	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CTGF—primary biliary cirrhosis	1.2e-05	0.000178	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GOT2—primary biliary cirrhosis	1.19e-05	0.000176	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CTGF—primary biliary cirrhosis	1.05e-05	0.000156	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ALB—primary biliary cirrhosis	1.05e-05	0.000154	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GOT2—primary biliary cirrhosis	1.05e-05	0.000154	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GGT1—primary biliary cirrhosis	1.03e-05	0.000152	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GOT1—primary biliary cirrhosis	1.03e-05	0.000152	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	1.02e-05	0.000151	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PPARGC1A—primary biliary cirrhosis	9.17e-06	0.000135	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GGT1—primary biliary cirrhosis	9.02e-06	0.000133	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GOT1—primary biliary cirrhosis	9.02e-06	0.000133	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	8.15e-06	0.00012	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PPARGC1A—primary biliary cirrhosis	8.03e-06	0.000119	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	7.58e-06	0.000112	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—AGT—primary biliary cirrhosis	7.14e-06	0.000105	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	6.5e-06	9.59e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	6.44e-06	9.51e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—AGT—primary biliary cirrhosis	6.26e-06	9.23e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	5.56e-06	8.21e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	5.56e-06	8.21e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	4.95e-06	7.3e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ALB—primary biliary cirrhosis	4.8e-06	7.09e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	3.85e-06	5.69e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	2.96e-06	4.37e-05	CbGpPWpGaD
